Share |

Content about pharmaceutical

August 25, 2011

No one knows more about wasteful spending than the government, and healthcare is on top of most people’s list when it comes to wasteful spending. Since 2009 the focus has shifted towards bringing down the cost of healthcare spending.

April 17, 2012

Washington, D.C.-based Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) which recently moved its headquarters from Rockville, has purchased rights to develop and commercialize a small molecule neurokinin 1 receptor (NK-1R) antagonist called VLY-686. VLY-686 is being licensed from pharmaceutical giant Eli Lilly & Co (NYSE:LLY).

July 11, 2011

Press Release

"Vanda Pharmaceuticals Enters into an Exclusive License Agreement with Probiomed S.A. de C.V. for Commercialization of Fanapt(TM) in Mexico

June 30, 2011

The Brilliant Achievement Award was presented to Human Genome Sciences CEO Thomas Watkins at the 16th Annual Chinese Biopharmaceutical Association Conference.

"The CBA Brilliant Achievement Award is given to honor outstanding individuals who have made significant contributions to science, technology, or business development in the bio pharmaceutical fields." said Zhifeng Long, Ph.D. Chair of the Conference Organizing Committee who was also honored and name President of the CBA for 2011 - 2012.